Noble Trims PT on TherapeuticsMD (TXMD) to $17.50 Following Q4 Results; Affirms at 'Buy'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. NKE
8. MU
9. PFE
10. AWK

Go back to Noble Trims PT on TherapeuticsMD (TXMD) to $17.50 Following Q4 Results; Affirms at 'Buy'

TherapeuticsMD (TXMD) Reports In-Line Q4 EPS

February 25, 2016 4:34 PM EST

TherapeuticsMD (NYSE: TXMD) reported Q4 EPS of ($0.10), in-line with the analyst estimate of ($0.10). Revenue for the quarter came in at $5.63 million versus the consensus estimate of $5.33 million.

For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.

... More